Productive and economic impact of pig lung lesions detected at slaughter
Detection of lung lesions in slaughtered pigs also allows estimation of economic losses.
articles about mycoplasma
Dysbiosis of gut microbiota and intestinal barrier dysfunction in pigs with pulmonary inflammation induced by Mycoplasma hyorhinis infection
Lung inflammation induced by M. hyorhinis infection can contribute to the dysbiosis of gut microbiota and intestinal barrier dysfunction.
The impact of discontinuing perinatal antibiotic treatments in piglets
Side effects of perinatal medications on the microbiota can be detrimental to animal health.
The effect of gilt flow management during acclimation on Mycoplasma hyopneumoniae detection
A similar M. hyopneumoniae detection pattern was observed regardless of gilt flow.
Mycoplasma hyopneumoniae vaccines
This article presents the main characteristics of the vaccines that can be found on the market.
PCR assay as a diagnostic tool (2/2): Uses and interpretation of the results
How to interpret a negative or positive PCR result with specific examples of what could be happening.
Boehringer Ingelheim's TwistPak® mixing platform for swine vaccines brings convenience and flexibility
TwistPak® allows for fresh mixing of Ingelvac CircoFLEX® and Ingelvac MycoFLEX® on farm in less than 5 seconds.
University of Minnesota swine professors receive awards at CVM Research Day
Dr. Maria Pieters and Dr. Noelle Noyes receive awards at the Points of Pride Research Day of the UMN College of Veterinary Medicine.
How does swine influenza virus facilitate secondary bacterial complications?
The influenza virus promotes colonization by secondary bacterial agents in the lung, facilitating their passage into the bloodstream.
Laboratory diagnostics: Mycoplasma hyopneumoniae
What laboratory diagnostic methods can I use to diagnose M. hyo? Which one should I choose according to the situation? How do I interpret the results?
Ceva receives positive opinion from EMA for Circovac® + Hyogen® Ready to Mix: DUO™ swine vaccines
The combination of products gives protection against PCV2 and Mycoplasma hyopneumoniae until 26 weeks of age.
Zoetis launches CircoMax® Myco to deliver broader coverage against PCV2
Unique PCV2 and M. hyopneumoniae ready-to-use, single-dose combination vaccine on the market.
Pharmgate: Aivlosin® WSG approved in U.S. and Canada to control Mycoplasma hyopneumoniae
This approval gives Aivlosin® WSG the broadest label indication of any product for the control of swine respiratory disease (SRD).
Zoetis Receives European Commission Marketing Authorization for CircoMax® Myco
First PCV2 and M. hyopneumoniae combination vaccine in the EU for pigs that includes two PCV2 genotypes for broader coverage against continuously evolving Porcine Circovirus.
Time to rethink Mycoplasma surveillance protocols for gilt introduction to negative sow herds
Traditional surveillance protocols for Mycoplasma hyopneumoniae should not become a tradition. In this article, the authors give us their field-based research approach for an updated surveillance protocol with increased diagnostic accuracy.
Principal co-infections of the porcine respiratory system
M. hyopneumoniae is involved in most of the co-infections of the porcine respiratory system. How does it act and what effects does it have?